(Date:11/26/2009)...cus Aureus ) and other drug-resistant bacteria cou...totype devices have been developed to offer safe, ..., Two prototype devices have been developed: one...hands and feet) in hospitals and public spaces whe...to shoot bacteria-killing agents into infested chr...
(Date:11/25/2009)...ath Research Laboratory in the University of Haifa...stigious Johnson & Johnson Focused Funding grant f...damage in Parkinson,s disease. The award, which is...ovation and excellence in science, was announced i...h at an event at the Hyatt Regency Hotel in New Je...
(Date:11/24/2009)...ribed by traditional healers in Brazil to treat a ...to fever and flu. , Now for the first time, resea...cientifically prove the pain relieving properties ...mint. , Testing this ancient South American herb ... was able to show that when prepared as a ,tea, t...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Celebrate June Is Dairy Month Beginning With Breakfast 48128 1Celebrate June Is Dairy Month Beginning With Breakfast 48128 2Windows XP Vista and Windows 7 Compatible Remote Control 4 0 Beta Released by IntelliAdmin LLC 48124 1Windows XP Vista and Windows 7 Compatible Remote Control 4 0 Beta Released by IntelliAdmin LLC 48124 2Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 1Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 2Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 3Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 4Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 5Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 6Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 7Afinitor 28R 29 Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma Leading to Phase III Trial 4554 8(Date:11/25/2009)..., , MARKHAM, ON, Nov. 25 /PRNewswire/ - Cyto...ldt, PhD to its Board of Directors. Dr. Moldt will...ative on the Company,s Board. The number of Board ...e are very pleased to welcome Peter Moldt to the b...ience and guidance as Cytochroma continues to make...
(Date:11/24/2009)... This release is available in German . , Wh...ion cards: RFID tags (Radio Frequency Identificati...ay life. They make it possible to label objects or...equency. The appropriate scanner can read and proc...can be affixed to goods under production condition...
(Date:11/24/2009)..., , SANTA CRUZ, Calif., Nov. 24 /PRNewsw...ned Bio Career Center, the nation,s leading online...ssionals. ,, Northwestern and Columbia Universi...her major life science training Institutions. ,...y for post-graduates in the life sciences. While t...
(Date:11/24/2009)... Health care employment g...ns the only one to show consistent growth during t...hospitals remain in trouble, and health systems ar...personnel, instead of just administrators. , ...ealth care employment continued growing in October...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4...AMIR, Israel, Jan. 14 Shamir,Optical Industry Ltd...of,innovative products and technology to the progr...t its board of directors had declared a dividend,d...ion (approximately NIS,15.1 million based on the J...or approximately US$ 0.243 (approximately NIS 0.91...
...nd HAIKOU, China, Jan. 14 /Xinhua-PRNewswire-First...a,) (OTC Bulletin Board: CPHI),which develops, man...aceutical products in China, today announced that ...itiate a proactive and targeted investor,relations...I, and their,collective team, will be advising the...
...an. 14 Today, The Woodbridge Group announced,the ...industry,s highest,levels of "Green" Polyurethane ...e strategy, BioFoam, a patented technology, substi...ing of polyurethane products. This,earth-friendly ...,applications includes; seat cushions, seat fabric...
Other Biology Technology:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 2China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 3Woodbridge Offers the Broadest Range of BioFoam(TM) 'Green' Polyurethane Automotive Interior Applications 2...apidCycler is the first instrument engineered to m...d by thousands of research centers worldwide. It u... are ideally suited for high-speed temperature cyc...rface-area-to-volume ratio. ,By combining glass c...
Freund's Incomplete Adjuvant, Modified from Calbiochem
...RY Array LNA microarray slides for microRNA expre...ides incorporate Exiqons unique Locked Nucleic Aci...ty and excellent mismatch discrimination for short... on less than 1 g total RNA (no need for microRNA ...
Tyrode's Salts solution from Sigma-Aldrich
Biology Products: